Elenco delle principali pubblicazioni scientifiche prodotte nel campo della Cardiologia e dell'Aritmologia

Molon G, Canali G, Girardi P, Salazzari GC.

TRATTAMENTO DELL’INTOSSICAZIONE DIGITALICA: UN CASO RISOLTO CON ANTICORPI SPECIFICI. 

Le basi Razionali della Terapia 1996; 26 (3): 181-6.

Molon G, Marangoni D, Barbieri E.

SPONTANEOUS VENTRICULAR TACHYCARDIA AND FIBRILLATION IN A PATIENT WITH A POSITIVE MICROVOLT T WAVE ALTERNANS TEST AND NEGATIVE ELECTROPHYSIOLOGICAL STUDY. 

PACE 2004; 27:1-3

G Boriani, L Padeletti, M Santini, M Gulizia, A Capucci, GL Botto, R Ricci, G Molon, M Accogli, A Vicentini, M Biffi, M Vimercati and A Grammatico

PREDICTORS OF ATRIAL ANTITACHYCARDIA PACING EFFICACY IN PATIENTS AFFECCTED BY BRADY-TACHY FORM OF SICK SYNUS SYNDROME AND IMPLANTED WITH A DDDRP DEVICE.

Journal of Cardiovascular Electrophysiology 2005 vol 16 (7): 714-723

A Capucci, M Santini, L Padeletti, M Gulizia, GL Botto, G Boriani, R Ricci, S Favale, F Zolezzi, N Dibelardino, G Molon, F Drago, GQ Villani, E Mazzini, M Vimercati, A Grammatico

MONITORED ATRIAL FIBRILLATION DURATION PREDICTS ARTERIAL EMBOLIC EVENTS IN PATIENTS SUFFERING FROM BRADYCARDIA AND ATRIAL FIBRILLATION IMPLANTED WITH ANTITACHYCARDIA PACEMAKERS.

JACC 2005 vol 46, 10: 1913-20

L Padeletti, M Santini, G Boriani, GL Botto, M Gulizia, G Molon, G Luzzi, G Senatore, F Giraldi, F Zolezzi, P Pieragnoli, F Pro, T DeSanto, A Grammatico.

LONG-TERM REDUCTION OF ATRIAL TACHYARRHYTMIA RECURRENCES IN PATIENTS PACED FOR BRADYCARDIA-TACHYCARDIA SYNDROME.

Heart Rhythm. 2005 Oct; 2(10):1047-57

G Molon, G Targher, A Costa, L Bertolini, E Barbieri, L Zenari

MEASUREMENT OF MICROVOLT T-WAVE ALTERNANS, A NEW ARRHYTHMIC RISK STRATIFICATION TEST, IN TYPE 2 DIABETIC PATIENTS WITHOUT CLINICAL CARDIOVASCULAR DISEASE.

Diabetic Medicine 2006; vol 23: 207-210

GM De Ferrari, C Klersy, P Ferrero, C Fantoni, D Salerno-Uriarte, L Manca, P Devecchi, G Molon, M Revera, A Curnis, S Sarzi-Braga, F Accardi, JA Salerno-Uriarte for the ALPHA Study Group

ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS: PREVALENCE IN DAILY PRACTICE AND EFFECT ON THE SEVERITY OF SYMPTOMS. DATA FROM THE ALPHA STUDY REGISTRY.

European Journal of Heart Failure 9 (2007) 502 - 509.

G.Molon, E Adamo, GM De Ferrari, F. Accardi, E. Dalla Vecchia, L. Sallusti, S. Ciaffoni, E. Barbieri

EFFECTS OF CARDIAC RESYNCHRONIZATION THERAPY ON INSULIN-LIKE GROWTH FACTOR-1 IN PATIENTS WITH ADVANCED HEART FAILURE.

Journal of Cardiovascular Medicine 2007; 8: 917 - 922.

G.Molon, A.Costa, L.Bertolini, L.Zenari, G.Arcaro, E.Barbieri, G.Targher

RELATIONSHIP BETWEEN POSITIVE MICROVOLT T-WAVE ALTERNANS AND POOR GLYCEMIC CONTROL IN TYPE 2 DIABETIC PATIENTS.

PACE 2007; vol 30: 1267 - 1272

JA Salerno-Uriarte, GM De Ferrari, C Klersy, RFE Pedretti, M Tritto, L Sallusti, L Libero, G Pettinati, G Molon, A Curnis, E Occhetta, F Morandi, P Ferrero, F Accardi, for the ALPHA Study Group Investigators.

PROGNOSTIC VALUE OF T-WAVE ALTERNANS IN PATIENTS WITH HEART FAILURE DUE TO NONISCHEMIC CARDIOMYOPATHY: RESULTS OF THE ALPHA STUDY.

JACC 2007; vol 50 (19):1896-904

G.Targher, A.Costa, L.Bertolini, D.Cian, G.Molon

RESPONSE: LETTER TO THE EDITOR

PACE 2008; vol 31 (2): 261

G Molon, E. Barbieri

L'ALTERNANZA DELL'ONDA T. SIGNIFICATO CLINICO E PROGNOSTICO.

Cardiology Science. Volume 7 (4): 180- 4

A.Capucci, G.Botto, G.Molon, A.Spampinato, S.Favale, A.Proclemer, A.Porfilio, T.Marotta, M.Vimercati, G.Boriani, on behalf of the DAPHNE study investigators.

THE DAPHNE STUDY: A RANDOMIZED TRIAL COMPARING SOTALOL VERSUS BETA-BLOCKERS TO TREAT SYMPTOMATIC ATRIAL FIBRILLATION IN BRADY-TACHYCARDIA SYNDROME PATIENTS IMPLANTED WITH AN ANTITACHYCARDIA PACEMAKER.

American Heart Journal 2008 156(2); 373

Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F, Favale S, Molon G, Ricci R, Biffi M, Russo G, Vimercati M, Corbucci G, Boriani G.

PRESENCE AND DURATION OF ATRIAL FIBRILLATION DETECTED BY CONTINUOUS MONITORING: CRUCIAL IMPLICATIONS FOR THE RISK OF THROMBOEMBOLIC EVENTS.

Journal of Cardiovascular Electrophysiology 2009, 20(3):241-8

M Anselmino, GM De Ferrari, R Massa, L Manca, M Tritto, G Molon, A Curnis, P Devecchi, S Sarzi Braga, G Bartesaghi, C Klersy, F Accardi, JA Salerno-Uriarte, for the ALPHA Study Group Investigators.

DETERMINANTS OF MORTALITY AND CARDIAC CAUSE HOSPITALIZATION IN A NON-ISCHEMIC COHORT OF HEART FAILURE PATIENTS - INSIGHTS FROM THE ALPHA STUDY.

PACE 2009 Mar;32 Suppl 1:S214-8

G.Boriani, M.Gasparini, M.Landolina, M.Lunati, M.Biffi, M. Santini, L.Padeletti, G.Molon, G.Botto, T.De Santo, S.Valsecchi

EFFECTIVENESS OF CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE PATIENTS WITH VALVULAR HEART DISEASE: COMPARISON WITH PATIENTS AFFECTED BY ISCHEMIC HEART DISEASE OR DILATED CARDIOMYOPATHY. THE INSYNC/INSYNC ICD ITALIAN REGISTRY.

European Heart Journal. 2009 Sep;30(18):2275-83.

Pedretti RF, Curnis A, Massa R, Morandi F, Tritto M, Manca L, Occhetta E, Molon G, De Ferrari GM, Sarzi Braga S, Raciti G, Klersy C, Salerno-Uriarte JA; ALPHA Study Group Investigators.

PROPORTION OF PATIENTS NEEDING AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ON THE BASIS OF CURRENT GUIDELINES: IMPACT ON HEALTHCARE RESOURCES IN ITALY AND THE USA. DATA FROM THE ALPHA STUDY REGISTRY.  

Europace. 2010 Aug;12(8):1105-11

M.Santini, M.Lunati, P.Defaye, J.Mermi, A.Proclemer, S. del Castillo-Arroys, G.Molon, E.Santi, T.de Santo, X.Navarro, A.Kloppe

PROSPECTIVE MULTICENTER RANDOMIZED TRIAL OF FAST VENTYRICULAR TACHYCARDIA TERMINATION BY PROLONGED VERSUS CONVENTIONAL ANTI-TACHYARRYTHMIA BURST PACING IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR PATIENTS - ATP DELIVERY FOR PAINLESS ICD THERAPY (ADVANCE-D) TRIAL RESULTS.

J Interv Card Electroph. 2010 Mar;27(2):127-35

Molon G, Solimene F, Melissano D, Curnis A, Belotti G, Marrazzo N, Marczyk J, Accardi F, Raciti G, Zecchi P.

BASELINE HEART RATE VARIABILITY PREDICTS CLINICAL EVENTS IN HEART FAILURE PATIENTS IMPLANTED WITH CARDIAC RESYNCHRONIZATION THERAPY: VALIDATION BY MEANS OF RELATED COMPLEXITY INDEX.

Ann Noninvasive Electrocardiol. 2010 Oct;15(4):301-7.

M.Santini, M.Gasparini, M.Landolina, M.Lunati, A.Proclemer, L Padeletti, D Catanzariti, G.Molon, GL Botto, L La Rocca, A Grammatico, G Boriani.

DEVICE-DETECTED ATRIAL TACHYAARRHYTHMIAS PREDICT ADVERSE OUTCOME IN REAL-WORLD PATIENTS WITH IMPLANTABLE BIVENTRICULAR DEFIBRILLATORS.

JACC. 2011; 57: 167-172

Molon G, Perrone C, Maines M, Costa A, Comisso J, Boi A, Moro E, Vergara G, Barbieri E.

ICD AND NEUROMODULATION DEVICES: IS PEACEFUL COEXISTENCE POSSIBLE?

PACE 2011, 34: 690-693)

GL Botto, G Boriani, S Favale, M Landolina, G Molon, C Tondo, M Biffi, G Grandinetti, P De Filippo, G Raciti and L Padeletti

TREATMENT OF ATRIAL FIBRILLATION WITH A DUAL DEFIBRILLATOR IN HEART FAILURE PATIENTS (TRADE HF): PROTOCOL FOR A RANDOMIZED CLINICAL TRIAL.

Trials 2011, 12: 44

Bonapace S, Targher G, Molon G, Rossi A, Costa A, Zenari L, Bertolini L, Cian D, Lanzoni L, Barbieri E

RELATIONSHIP BETWEEN EARLY DIASTOLIC DYSFUNCTION AND ABNORMAL MICROVOLT T-WAVE ALTERNANS IN PATIENTS WITH TYPE 2 DIABETES.

Circ Cardiovascular Imaging 2001; 4: 408-414

G.Boriani, M.Gasparini, M.Landolina, M.Lunati, M.Biffi, M. Santini, L.Padeletti, G.Molon, G.Botto, T.De Santo, S.Valsecchi

IMPACT OF MITRAL REGURGITATION ON THE OUTCOME OF PATIENTS TREATED WITH CRT-D: DATA FROME THE INSYNC ICD ITALIAN REGISTRY.

PACE 2012 Feb;35(2):146-54

Bonapace S, Perseghin G, Molon G, Canali G, Costa A, Bertolini L, Cian D, Zoppini G, Barbieri E, Targher G

NON-ALCOHOLIC FATTY LIVER IS ASSOCIATED WITH LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH TYPE 2 DIABETES.

Diabetes Care 2012 Feb;35(2):389-95

Molon G, Lanzoni L, Dalla Chiara E, Barbieri E

ANEURISMA DEL SENO DI VALSALVA IN UN PAZIENTE ANZIANO ASINTOMATICO

Giornale Italiano di Cardiologia 2013;14(2):153-154

Botto GL, Dicandia CD, Mantica M, La Rosa CL, D'Onofrio A, Bongiorni MG, Molon G, Verlato R, Raciti G, Occhetta E.

CLINICAL CHARACTERISTICS, MORTALITY, CARDIAC HOSPITALIZATION AND VENTRICULAR ARRHYTHMIAS IN PATIENTS UNDERGOING CRT-D IMPLANTATION: RESULTS FROM THE ACTION-HF STUDY.

J Cardiovasc Electrophysiol. 2013 Feb;24(2):173-181

G.Morani, M.Gasparini, F.Zanon, E.Casali, A.Spotti, A.Reggiani, E.Bertaglia, F.Solimene, G.Molon, M.Accogli, C.Tommasi, A.Paoletti Perini, C.Ciardiello, L.Padeletti

CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATOR IMPROVES LONG-TERM SURVIVAL COMPARED WITH CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKER IN PATIENTS WITH A CLASS IA INDICATION FOR CARDIACRESYNCHORNIZATION THERAPY: DATA FROM THE CONTAK ITALIAN REGISTRY.

Europace 2013

R Verlato, D.Facchin, D.Catanzariti, G.Molon, G.Zanotto, G.Morani, M.Brieda, F.Zanon, P.Delise, L.Leoni, J.Comisso, C.Campo

CLINICAL OUTCOMES IN PATIENTS WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AND SPRINT FIDELIS LEADS

Heart. 2013 Jun;99(11):799-804

Molon G, Cohen RJ, de Santo T, Costa A, Barbieri E

CLINICAL USE OF MICROVOLT T-WAVE ALTERNANS IN PATIENTS WITH DEPRESSED LEFT VENTRICULAR FUNCTION ELIGIBLE FOR ICD IMPLANTATION: MORTALITY OUTCOMES AFTER LONG TERM FOLLOW-UP.

Int Journ of Cardiology, 2013 Oct 3;168(3):3038-40

Molon G, Zanotto G, Rahue W, Facchin D, Leoni L, Morani G, Calvi V, Catanzariti D, Costa A, Zago L, Comisso J, Varbaro A, Santini M

PULMONARY FLUID OVERLOAD MONITORING IN HEART FAILURE PATIENTS WITH SINGLE AND DUAL CHAMBER DEFIBRILLATORS

Journal of Cardiovascular Medicine, 2014 Apr;15(4):307-14

D'Onofrio A, Botto GL, Mantica M, La Rosa C, Occhetta E, Verlato R, Molon G, Ammendola E, Villani GQ, Bongiorni MG, Gelmini GP, Ciardiello C, Dicandia CD.

 THE INTERVENTRICULAR CONDUCTION TIME IS ASSOCIATED WITH RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY: INTERVENTRICULAR ELECTRICAL DELAY.

Int J Cardiol. 2013 Oct 12;168(5):5067-8  



Is microvolt T-wave alternans testing suitable for patients recently hospitalized due to decompensated heart failure?

Eur J Heart Fail. 2014 Jan;16(1):112G.

D'Onofrio A, Botto G, Mantica M, LA Rosa C, Occhetta E, Verlato R, Molon G, Ammendola E, Villani GQ, Bongiorni MG, Bianchi V, Gelmini GP, Valsecchi S, Ciardiello C.

Incremental value of larger interventricular conduction time in improving cardiac resynchronization therapy outcome in patients with different QRS duration. 

J Cardiovasc Electrophysiol. 2014 May;25(5):500-6G

Zoppo F, Facchin D, Molon G, Zanotto G, Catanzariti D, Rossillo A, Baccillieri MS, Menard C, Comisso J, Gentili A, Grammatico A, Bertaglia E, Proclemer A.

Improving atrial fibrillation detection in patients with implantable cardiac devices by means of a remote monitoring and management application.

Pacing Clin Electrophysiol. 2014 Dec;37(12):1610-8


Kolb C, Sturmer M, Sick P, Reif S, Davy JM, Molon G, Schwab JO, Mantovani G, Dan D, Lennerz C, Borri-Brunetto A, Babuty D.

Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.

JACC Heart Fail. 2014 Dec;2(6):611-9


Baccillieri MS, Gasparini G, Benacchio L, Zorzi A, Marras E, Zerbo F, Tomasi L, Vaccari D, Pastore G, Bonanno C, Molon G, Zanotto G, Fusco A, Carasi M, Zorzi A, Calzolari V, Ignatiuk B, Cannas S, Vaglio A, Al Bunni M, Pedrini A, Olivieri A, Rampazzo R, Minicuci N, Corrado D, Verlato R.

Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study.

J Interv Card Electrophysiol. 2015 Jun;43(1):45-54

G Molon, Canali G, Casu G, Mazzone P, Barbato G, Ramondo A, Saccà S, Scaglione M, Senatore G, Solimene F, Grassi G, Nardi S, Luise R.

LETTER TO THE EDITOR

G Ital Cardiol (Rome). 2015 Mar;16(3):188-90.

Mugnai G, Sieira J, Ciconte G, Hervas MS, Irfan G, Saitoh Y, Hünük B, Ströker E, Velagic V, Wauters K, Tondo C, Molon G, Asmundis C, Brugada P, Chierchia GB.

One Year Incidence of Atrial Septal Defect after PV Isolation: A Comparison Between Conventional Radiofrequency and Cryoballoon Ablation.

Pacing Clin Electrophysiol. 2015 May 14.

Bonapace S, Rossi A, Lipari P, Bertolini L, Zenari L, Lanzoni L, Canali G, Molon G, Mantovani A, Zoppini G, Bonora E, Barbieri E, Targher G.

Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes.

J Diabetes Complications. 2015 May 16.

Merchant FM, Salerno-Uriarte JA, Caravati F, Falcone S, Molon G, Marangoni D, Raczak G, Danilowicz-Szymanowicz L, Pedretti RF, Sarzi Braga S, Ikeda T, Calo L, Martino A, Erciyes D, Piancastelli M, Maury P, Cohen RJ, Armoundas AA.

Prospective Use of Microvolt T-Wave Alternans Testing to Guide Primary Prevention Implantable Cardioverter Defibrillator Therapy.

Circ J. 2015 Jun 15